Dosage protocol · Healing & Recovery
BPC-157 10 mg
The 10 mg BPC-157 vial is the workhorse size for a full recovery block. Reconstituted with 3 mL of bacteriostatic water it settles at 3.33 mg/mL, which puts a typical 200–600 mcg daily dose in the easy-to-read 6–18 unit range on a standard U-100 syringe. The chart below is built around gradual titration over an 8–12 week course.
- Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL concentration.
- Typical daily range: 200–600 mcg once daily (gradual titration).
- Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
BAC water3.0mL
Concentration3.33mg/mL
Reconstitution
BPC-157 dosage chart
BPC-157 dosage chart
| Week | Dose | Draw |
|---|---|---|
| Weeks 1–2 | 200 mcg0.2 mg | 6 units0.06 mL |
| Weeks 3–4 | 400 mcg0.4 mg | 12 units0.12 mL |
| Weeks 5–8+ | 600 mcg0.6 mg | 18 units0.18 mL |
How much to draw
The Draw column shows exactly where to stop on a U-100 insulin syringe. Different vial size or dose? The calculator below recomputes it live.
Supplies needed
Supplies needed
Peptide vial
The lyophilized compound
Bacteriostatic water
For reconstitution
U-100 insulin syringes
One per injection
Alcohol swabs
Stopper + site each time
How it works
BPC-157 is a synthetic 15-amino-acid sequence derived from a protein found in gastric juice. Research attention centres on its apparent effect on angiogenesis — the formation of new blood vessels — and on the up-regulation of growth-factor receptors that tissue relies on to repair itself.
In preclinical models it has been associated with faster healing of tendon, ligament and muscle, protection of the gut lining, and modulation of the nitric-oxide pathway that governs local blood flow. None of this is established in controlled human trials, and BPC-157 is not an approved drug in most jurisdictions — the protocol here is an educational reference, not a clinical recommendation.
Benefits & side effects
- Studied for connective-tissue repair (tendon, ligament, muscle) in animal models.
- Associated with cytoprotection of the gastrointestinal tract in preclinical work.
- Generally reported as well tolerated at the doses studied; occasional mild injection-site reactions.
- Human efficacy and long-term safety are not established — treat all claims with caution.
Injection technique
- Swab the vial stopper and the injection site with alcohol and let both dry.
- Draw to your target unit mark on a U-100 insulin syringe; tap out air bubbles.
- Pinch a fold of skin and insert at 45–90° into subcutaneous tissue (abdomen is common).
- Inject slowly and steadily; no need to aspirate for a subcutaneous injection.
- Rotate sites between injections to avoid local irritation, and use a fresh syringe each time.
Calculator
Plan your own dose
Reconstituting a different vial size or targeting a different dose? Run the numbers.
1
Reconstitution
mg
mL
Concentration—
Per unit (0.01 mL)—
Per 10 units (0.1 mL)—
2
Your dose
Doses per vial—
Vial lasts—
Draw to
— units
=
—
Other vial sizes
